Join HemoCue at ADLM 2026 Clinical Lab Expo
From July 26–30, HemoCue will be present at this year’s ADLM conference in Anaheim, California, together with our fellow Danaher operating companies to showcase how our collective innovations are accelerating the power of science and technology to improve human health.
Request an appointment now for a tailored demo of solutions that matter to you.
July 26-30 | Anaheim, CA | Danaher Booth #3237
We’re Accelerating the Power of Science and Technology to Improve Human Health
Our impact spans from lab to life, speeding the translation of advanced science to real-world impact and improving the lives of millions of patients globally.
Guided by our culture of continuous improvement, we’re turning scientific potential into progress and helping providers deliver accurate answers sooner —because time saves lives, and speed with certainty matters.
Focus areas for HemoCue
At ADLM Clinical Lab Expo 2026, HemoCue will highlight key solutions that support patient care in:
Explore how rapid, quantitative plasma-free hemoglobin testing can strengthen your program’s hemolysis monitoring. The HemoCue® Plasma/Low Hb System provides quantitative plasma-free hemoglobin (PfHb) values within 60 seconds after centrifugation.
Discover how point-of-care testing can improve efficiency and promote patient satisfaction in gestational diabetes screening. The HemoCue® Glucose 201 System is CLIA-waived and delivers lab-quality results at the point of care, enabling reliable diabetes diagnosis without the need for lab send-outs.
Learn how point-of-care testing can be an ideal solution for ASCs with the goal of improving patient care. HemoCue® Glucose 201 Systems are ideal solutions for ASCs with a goal to promote surgical readiness, reduce deferrals, and lower infection risk while maintaining regulatory compliance.
When Time Saves Lives, Speed with Certainty Matters
At Danaher we unite diagnostics, life sciences, and biotech to deliver faster, smarter solutions—because lives depend on it.
The impact of our industry-leading businesses – Beckman Coulter Diagnostics, Beckman Coulter Life Sciences, Cepheid, Cytiva, HemoCue, Leica Biosystems, Radiometer and SCIEX – spans from Lab to Life, speeding the translation of advanced science to real-world impact by:
Delivering faster, more reliable answers to help providers make confident decisions, improve treatment options and save lives
Collaborating to discover new biomarkers and develop high-resolution tools to unlock breakthroughs that transform patient care
Expanding access to diagnostics and therapeutics for millions of patients, leveraging our global scale and operational expertise to improve human health
